4//SEC Filing
Herrmann John A III 4
Accession 0001209191-22-061705
CIK 0001000694other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:02 PM ET
Size
10.4 KB
Accession
0001209191-22-061705
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Herrmann John A III
SVP, General Counsel
Transactions
- Tax Payment
Common Stock
2022-12-14$17.23/sh−700$12,061→ 8,449 total - Exercise/Conversion
Common Stock
2022-12-14+2,100→ 9,149 total - Exercise/Conversion
Restricted Stock Units
2022-12-14−2,100→ 2,100 total→ Common Stock (2,100 underlying)
Holdings
- 3,384(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]The shares were received by the Reporting Person in connection with vesting of restricted stock units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
- [F3]The shares were withheld by the Company to satisfy tax withholding obligations in connection with the vesting of RSUs.
- [F4]The shares reported on this Form 4 are subject to a lock-up agreement between the Reporting Person, J.P. Morgan Securities LLC and Jefferies LLC, dated December 14, 2022.
- [F5]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F6]The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001610928
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:02 PM ET
- Size
- 10.4 KB